Annexin A5 suppression promotes the progression of cervical cancer

Arch Gynecol Obstet. 2023 Mar;307(3):937-943. doi: 10.1007/s00404-022-06524-1. Epub 2022 Jul 7.

Abstract

Background: Cervical cancer is a common malignant gynecological disease that threatens the health of women all over the world. The abnormal expression of Annexin A5 (ANXA5) is closely related to the biological behavior of various malignant tumors, however, the relationship between ANXA5 and cervical cancer is still unclear. Therefore, the effects of low expression of ANXA5 on the proliferation, apoptosis, migration and invasion of cervical cancer cells (HeLa) and its related mechanism were explored.

Methods: The cells were divided into three groups: ANXA5-si group, negative control group and blank group. RNA interference was used to suppress ANXA5 expression. 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, colony formation assay, flow cytometry and propidium iodide (PI) staining, wound healing assay and transwell assay were employed to detect cell proliferation, apoptosis, migration and invasion respectively. Meanwhile, gene expression was detected by qPCR and Western blotting.

Results: ANXA5 suppression lead to the increase of proliferation, migration, invasion and the decrease of apoptosis of cervical cancer HeLa cells. Furthermore, the expression of both pPI3K and pAkt increased.

Conclusion: ANXA5 might inhibit Hela cells proliferation and metastasis by regulating PI3K/Akt signal pathway.

Keywords: Annexin A5; Cervical cancer; Metastasis; PI3K/Akt pathway; Proliferation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Annexin A5 / genetics
  • Annexin A5 / metabolism
  • Annexin A5 / pharmacology
  • Apoptosis / genetics
  • Cell Line, Tumor
  • Cell Movement / genetics
  • Cell Proliferation / genetics
  • Female
  • HeLa Cells
  • Humans
  • Phosphatidylinositol 3-Kinases / metabolism
  • Proto-Oncogene Proteins c-akt / metabolism
  • Signal Transduction
  • Uterine Cervical Neoplasms* / pathology

Substances

  • Annexin A5
  • Phosphatidylinositol 3-Kinases
  • Proto-Oncogene Proteins c-akt